About 59% of patients reported new headaches during
the acute stage of Covid-19.
A retrospective cohort study by Louis Poncet‐Megemont et al. revealed a high incidence of new headache onsets during the COVID-19 infection in French patients.
As already known, people with viral infections usually suffer from headaches. Remarkably, early Chinese studies described a comparatively low prevalence (12‐15%) of headaches linked with Covid‐19.
This study included laboratory-verified or chest‐CT‐confirmed Covid‐19 infection patients identified between February and April 2020 in a dedicated laboratory of Clermont‐Ferrand University Hospital. They had a follow-up for 1-month post-recovery.
On the whole, 139 consecutive patients (mean age of 48.5 years; 62.6% of women) were phone interviewed a month following withdrawal of fever and dyspnea. Generally, 59.0% of people with Covid‐19 had a mild ailment, 36.7% had a severe ailment, and 4.3% had a critical disease.
As found, 82 (59.0%) patients described new headaches through the acute phase and 3.6% had continued headaches a month following fever and dyspnea remission. 60.4% and 58.3% of the patients also frequently experienced anosmia and ageusia.
These 2 symptoms continued in 14.4% and 11.5% of Covid‐19 patients a month post-recovery. Headaches were neither evidently linked with anosmia, nor with ageusia, and were not linked with disease severity (in those requiring hospitalization or ICU).
HEADACHE
High Prevalence of Headaches During Covid‐19 Infection: A Retrospective Cohort Study
Louis Poncet‐Megemont et al.
Comments (0)